Clinical and Imaging Characteristics of Severe Mpox: A Case Study Involving 16 Patients from Beijing, China - Takeaways - MDSpire

Clinical and Imaging Characteristics of Severe Mpox: A Case Study Involving 16 Patients from Beijing, China

  • By

  • Fuchun Wang

  • Yuan Fang

  • Zhongkai Zhou

  • Hao Liu

  • Jiahao Ji

  • Lin Jia

  • Han Jia

  • Luyao Zheng

  • Wen Wang

  • Caiping Guo

  • Chunwang Yuan

  • Yue Yin

  • Juming Ma

  • Hongjun Li

  • Budong Chen

  • Junyi Duan

  • Tao Huang

  • Guanghui Zhang

  • Taiyi Jiang

  • Tong Zhang

  • Wei Wang

  • January 20, 2026

  • 0 min

Share

  • 1

    Mpox, caused by MPXV, has evolved into a global public health threat, with over 98,000 cases reported worldwide as of July 2024.

  • 2

    Severe mpox cases often present with complications affecting multiple organs and are more common in individuals with compromised immune systems, particularly those with HIV.

  • 3

    The study analyzed 16 severe mpox cases in Beijing, focusing on clinical and imaging characteristics to aid in early diagnosis and treatment.

  • 4

    Severe mpox is characterized by atypical rashes, significant lymphadenopathy, and complications that can lead to high morbidity and mortality.

  • 5

    Imaging, particularly chest CT scans, plays a crucial role in diagnosing severe mpox and monitoring associated complications.

Original Source(s)

Clinical and Imaging Characteristics of Severe Mpox: A Case Study Involving 16 Patients from Beijing, China

  • by Fuchun Wang, Yuan Fang, Zhongkai Zhou, Hao Liu, Jiahao Ji, Lin Jia, Han Jia, Luyao Zheng, Wen Wang, Caiping Guo, Chunwang Yuan, Yue Yin, Juming Ma, Hongjun Li, Budong Chen, Junyi Duan, Tao Huang, Guanghui Zhang, Taiyi Jiang, Tong Zhang, Wei Wang

  • January 20, 2026

Related Content

7 Days Noninferior in Bacteremia

BALANCE compared 7 vs 14 days of treatment among hospitalized patients with bloodstream infections.

Shorter TB Regimens Advance Care

Review highlights shorter tuberculosis regimens while warning that rising bedaquiline resistance may threaten future progress.

The hantavirus is a wake-up call. Will the Trump administration answer it?